Apical hypertrophic cardiomyopathy Yamaguchi syndrome
Acta méd. colomb
;
46(4): 54-57, Oct.-Dec. 2021. graf
Artigo
em Inglês
|
LILACS-Express
| LILACS
| ID: biblio-1374090
ABSTRACT
Abstract Introduction:
apical hypertrophic cardiomyopathy (HCM) accounts for 15% of patients with HCM in Japan. However, in our country it is a rare diagnosis. In this entity, the apex is almost exclusively affected, most commonly in the left ventricle. It is diagnosed by finding apical thickening greater than 15 mm or a ratio of left ventricular apical to basal wall thickness >1.3-1.5. It is treated symptomatically with beta blockers and automatic defibrillator implantation for primary prevention of sudden death. Case presentation a 59-year-old patient in whom apical HCM, or Yamaguchi syndrome, was found incidentally.Conclusion:
apical HCM is a rare entity, in many cases asymptomatic. Its prompt diagnosis allows early treatment and prevents cardiovascular outcomes, including fatal ones. (Acta Med Colomb 2021; 46. DOIhttps//doi.org/10.36104/amc.2021.2082).
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Idioma:
Inglês
Revista:
Acta méd. colomb
Assunto da revista:
Medicina
Ano de publicação:
2021
Tipo de documento:
Artigo
País de afiliação:
Colômbia
Instituição/País de afiliação:
Clínica Imbanaco/CO
/
Universidad Libre/CO
/
Universidad del Valle/CO
Similares
MEDLINE
...
LILACS
LIS